Key facts
- This page summarizes Itamar Shimrat's Form 4 filing for Cell Source, Inc. (CLCS).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Jun 2021, 13:43.
Itamar Shimrat - 08 Mar 2021 Form 4 Insider Report for Cell Source, Inc. (CLCS)
- Reporting relationship
- President, Treasurer and CFO, Director
- Issuer ticker
- CLCS
- Reported as of
- 08 Mar 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Itamar Shimrat
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Itamar Shimrat filed Form 4 for Cell Source, Inc. (CLCS) on 10 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLCS
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +750,000
- Change %
- Price
- $0.000000
- Shares after
- 750,000
- Date
- 08 Mar 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 750,000
- Exercise price
- $1.00
CLCS
transaction
Derivative
Director Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +600,000
- Change %
- Price
- $0.000000
- Shares after
- 600,000
- Date
- 08 Mar 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 600,000
- Exercise price
- $1.00
* marks a reported price that did not pass the local price check.